Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – MENAFN.COM
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell ImmunityVancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology…
(MENAFN – Newsfile Corp) BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related…
-
Noosa News17 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General24 hours agoMinecraft mayhem: ‘Chicken jockey’ chaos reaches Australian cinemas
-
Noosa News20 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General16 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call